{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T20:11:15Z","timestamp":1783195875909,"version":"3.54.6"},"reference-count":43,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jcyt.2020.06.006","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T08:59:30Z","timestamp":1599209970000},"page":"699-711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effects of stem cells on non-ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"22","author":[{"given":"Liang","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LingHui","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JianPing","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YueMin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jcyt.2020.06.006_bib0001","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.healun.2011.08.003","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report\u20142011","volume":"30","author":"Stehlik","year":"2011","journal-title":"J Heart Lung Transplant"},{"issue":"11","key":"10.1016\/j.jcyt.2020.06.006_bib0002","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jacc.2011.06.016","article-title":"10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice","volume":"58","author":"Strauer","year":"2011","journal-title":"J Am Coll Cardiol."},{"issue":"3","key":"10.1016\/j.jcyt.2020.06.006_bib0003","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ahj.2008.11.011","volume":"157","author":"Dill","year":"2009","journal-title":"Am Heart J."},{"issue":"10","key":"10.1016\/j.jcyt.2020.06.006_bib0004","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.amjcard.2009.06.057","article-title":"Effect of intracoronary injection of mononuclear bone marrow stem cells on left ventricular function in patients with acute myocardial infarction","volume":"104","author":"Plewka","year":"2009","journal-title":"Am J Cardiol."},{"issue":"5","key":"10.1016\/j.jcyt.2020.06.006_bib0005","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/01.RES.0000214407.58341.c8","article-title":"Intracoronary administration of circulating blood-derived progenitor cells after recanalization of chronic coronary artery occlusion improves endothelial function","volume":"98","author":"Erbs","year":"2006","journal-title":"Circ Res."},{"key":"10.1016\/j.jcyt.2020.06.006_bib0006","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019).","year":"2019"},{"key":"10.1016\/j.jcyt.2020.06.006_bib0007","doi-asserted-by":"crossref","first-page":"d2234","DOI":"10.1136\/bmj.d2234","article-title":"Angiotensin Receptor Blockers and Risk of Myocardial Infarction: Meta-Analyses and Trial Sequential Analyses of 147 020 Patients From Randomised Trials","volume":"342","author":"Bangalore","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jcyt.2020.06.006_bib0008","doi-asserted-by":"crossref","first-page":"h1354","DOI":"10.1136\/bmj.h1354","article-title":"Restrictive Versus Liberal Transfusion Strategy for Red Blood Cell Transfusion: Systematic Review of Randomised Trials With Meta-Analysis and Trial Sequential Analysis","volume":"350","author":"Holst","year":"2015","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.jcyt.2020.06.006_bib0009","first-page":"207","article-title":"Autologous bone marrow mononuclear cell delivery to dilated cardiomyopathy patients: a clinical trial","volume":"7","author":"Kaparthi","year":"2008","journal-title":"African Journal of Biotechnology"},{"issue":"2","key":"10.1016\/j.jcyt.2020.06.006_bib0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1590\/S1516-31802008000200003","article-title":"Autologous transplantation of bone marrow mononuclear stem cells by mini-thoracotomy in dilated cardiomyopathy: technique and early results","volume":"126","author":"Kalil","year":"2008","journal-title":"Sao Paulo Med J"},{"issue":"6","key":"10.1016\/j.jcyt.2020.06.006_bib0011","first-page":"450","article-title":"Functional Improvement in Patients With Dilated Cardiomyopathy After the Intracoronary Infusion of Autologous Bone Marrow Mononuclear Cells","volume":"66","author":"de Lezo","year":"2013","journal-title":"Rev Esp Cardiol"},{"issue":"10","key":"10.1016\/j.jcyt.2020.06.006_bib0012","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1590\/S0100-879X2010007500093","article-title":"A safety and feasibility study of cell therapy in dilated cardiomyopathy","volume":"43","author":"Martino","year":"2010","journal-title":"Braz J Med Biol Res"},{"issue":"5","key":"10.1016\/j.jcyt.2020.06.006_bib0013","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/CIRCHEARTFAILURE.109.855023","volume":"2","author":"Fischer-Rasokat","year":"2009","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jcyt.2020.06.006_bib0014","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3727\/096368910X514648","article-title":"Global Contractility Increment in Nonischemic Dilated Cardiomyopathy After Free Wall-Only Intramyocardial Injection of Autologous Bone Marrow Mononuclear Cells: An Insight Over Stem Cells Clinical Mechanism of Action","volume":"19","author":"Sant'anna","year":"2010","journal-title":"Cell Transplantation"},{"key":"10.1016\/j.jcyt.2020.06.006_bib0015","doi-asserted-by":"crossref","unstructured":"Baeza Garz\u00f3n F, Romero M, Su\u00e1rez de Lezo J, Ojeda Pineda S, Herrera C, Su\u00e1rez de Lezo J. Idiopathic Dilated Cardiomyopathy Treated With Intracoronary Infusion of Autologous Bone Marrow Cells: Long-term Follow-up. Rev Esp Cardiol (Engl Ed), 2015;68(8):726-8.","DOI":"10.1016\/j.rec.2015.03.012"},{"issue":"12","key":"10.1016\/j.jcyt.2020.06.006_bib0016","first-page":"1087","article-title":"Effects of intracoronary autologous bone marrow mononuclear cells transplantation in patients with dilated cardiomyopathy","volume":"36","author":"CHEN","year":"2008","journal-title":"Chin J Cardiol"},{"issue":"10","key":"10.1016\/j.jcyt.2020.06.006_bib0017","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","volume":"121","author":"Bartolucci","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jcyt.2020.06.006_bib0018","first-page":"121","article-title":"Autologous peripheral blood stem cells transplantation for the treatment of dilated cardiomyopathy: a 24-month follow-up in 38 cases","volume":"14","author":"Wu","year":"2010","journal-title":"J Clin Rehabil Tiss Eng Res"},{"key":"10.1016\/j.jcyt.2020.06.006_bib0019","first-page":"3045","article-title":"Peripheral blood stem cell transplantation in the treatment of dilated cardiomyopathy: a 3-month follow-up in 42 cases","volume":"12","author":"Zhang","year":"2008","journal-title":"J Clin Rehabil Tiss Eng Res"},{"key":"10.1016\/j.jcyt.2020.06.006_bib0020","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10517-010-0889-0","article-title":"Safety and efficiency of transplantation of allogenic multipotent stromal cells in surgical treatment of dilatated cardiomyopathy","volume":"149","author":"Fatkhutdinov","year":"2010","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.jcyt.2020.06.006_bib0021","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.jcyt.2013.01.115","article-title":"Transplantation of autologous bone marrow cells, improve the ejection fraction in patients with dilated cardiomyopathy of diverse etiology","volume":"15","author":"Bartolucci","year":"2013","journal-title":"Cytotherapy"},{"issue":"22","key":"10.1016\/j.jcyt.2020.06.006_bib0022","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/CIRCULATIONAHA.113.007412","article-title":"Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices","volume":"129","author":"Ascheim","year":"2014","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jcyt.2020.06.006_bib0023","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.healun.2017.01.008","article-title":"A randomized study of autologous bone marrow-derived stem cells in pediatric cardiomyopathy","volume":"36","author":"Pincott","year":"2017","journal-title":"J Heart Lung Transplant."},{"issue":"2","key":"10.1016\/j.jcyt.2020.06.006_bib0024","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/CIRCRESAHA.116.309717","article-title":"Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial","volume":"120","author":"Butler","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.jcyt.2020.06.006_bib0025","first-page":"575","article-title":"Comparative study on the efficacy of intracoronary infusion with various types of autologous bone marrow stem cells for patients with dilated cardiomyopathy","volume":"40","author":"Xiao","year":"2012","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"issue":"11","key":"10.1016\/j.jcyt.2020.06.006_bib0026","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2006.07.057","article-title":"AIIMS Cardiovascular Stem Cell Study Group. Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial","volume":"48","author":"Seth","year":"2006","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jcyt.2020.06.006_bib0027","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cardfail.2010.11.007","article-title":"Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy","volume":"17","author":"Vrtovec","year":"2011","journal-title":"J Card Fail"},{"issue":"1","key":"10.1016\/j.jcyt.2020.06.006_bib0028","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.112.276519","article-title":"Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up","volume":"112","author":"Vrtovec","year":"2013","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.jcyt.2020.06.006_bib0029","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.5966\/sctm.2015-0070","article-title":"REVIVE Trial: Retrograde Delivery of Autologous Bone Marrow in Patients With Heart Failure","volume":"4","author":"Patel","year":"2015","journal-title":"Stem Cells Transl Med"},{"issue":"44","key":"10.1016\/j.jcyt.2020.06.006_bib0030","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1093\/eurheartj\/ehv390","article-title":"Randomized trial of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with non-ischaemic dilated cardiomyopathy: the REGENERATE-DCM clinical trial","volume":"36","author":"Hamshere","year":"2015","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jcyt.2020.06.006_bib0031","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/sctm.17-0197","article-title":"CD34+ Cell Transplantation Improves Right Ventricular Function in Patients with Nonischemic Dilated Cardiomyopathy","volume":"7","author":"Frljak","year":"2018","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"10.1016\/j.jcyt.2020.06.006_bib0032","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ijcard.2008.06.002","article-title":"Granulocyte-colony stimulating factor or granulocyte-colony stimulating factor associated to stem cell intracoronary infusion effects in non-ischemic refractory heart failure","volume":"138","author":"Bocchi","year":"2010","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.jcyt.2020.06.006_bib0033","first-page":"437","article-title":"Direct intramyocardial transthoracic transplantation of bone marrow mononuclear cells for non-ischemic dilated cardiomyopathy: INTRACELL, a prospective randomized controlled trial","volume":"29","author":"Sant'Anna","year":"2014","journal-title":"Rev Bras Cir Cardiovasc"},{"issue":"42","key":"10.1016\/j.jcyt.2020.06.006_bib0034","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/eurheartj\/ehv477","article-title":"Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study)","volume":"36","author":"Martino","year":"2015","journal-title":"Eur Heart J."},{"key":"10.1016\/j.jcyt.2020.06.006_bib0035","first-page":"107","article-title":"A prospective, randomized, controlled trial of autologous mesenchymal stem cells transplantation for dilated cardiomyopathy","volume":"34","author":"Wang","year":"2006","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.jcyt.2020.06.006_bib0036","first-page":"2","article-title":"Transplantation of autologous bone marrow mononuclear cells on patients with idiopathic dilated cardiomyopathy: early results on effect and security","volume":"34","author":"Rong-chong","year":"2006","journal-title":"Chin J Cardiol"},{"issue":"2","key":"10.1016\/j.jcyt.2020.06.006_bib0037","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1536\/ihj.16-328","article-title":"Randomized Comparative Study on the Efficacy of Intracoronary Infusion of Autologous Bone Marrow Mononuclear Cells and Mesenchymal Stem Cells in Patients With Dilated Cardiomyopathy","volume":"58","author":"Xiao","year":"2017","journal-title":"Int Heart J."},{"issue":"15","key":"10.1016\/j.jcyt.2020.06.006_bib0038","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jacc.2009.11.070","article-title":"The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial long-term follow-up study","volume":"55","author":"Seth","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.jcyt.2020.06.006_bib0039","first-page":"1378","article-title":"Stem cell therapy for the treatment of nonischemic cardiomyopathy: a systematic review of the literature and meta-analysis of randomized controlled trials","volume":"30","author":"Marquis-Gravel","year":"2014","journal-title":"Can J Cardiol"},{"issue":"1","key":"10.1016\/j.jcyt.2020.06.006_bib0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13287-016-0441-x","article-title":"systematic review of randomised controlled trials examining the therapeutic effects of adult bone marrow-derived stem cells for non-ischaemic dilated cardiomyopathy","volume":"7","author":"Lu","year":"2016","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.jcyt.2020.06.006_bib0041","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/eurjhf\/hfp101","article-title":"Route of delivery and baseline left ventricular ejection fraction, key factors of bone marrow-derived cell therapy for ischaemic heart disease","volume":"11","author":"Brunskill","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jcyt.2020.06.006_bib0042","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1479-5876-8-88","article-title":"Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy","volume":"8","author":"Lin","year":"2010","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2020.06.006_bib0043","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/CCM.0b013e31819c0667","article-title":"Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy","volume":"37","author":"Sun","year":"2009","journal-title":"Crit Care Med"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324920307805?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324920307805?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:41:45Z","timestamp":1761442905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324920307805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1465324920307805"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2020.06.006","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of stem cells on non-ischemic cardiomyopathy: a systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2020.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}